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Brain morphogenesis is an important process contributing to higher-order cognition, however
our knowledge about its biological basis is largely incomplete. Here we analyze 118 neu-
roanatomical parameters in 1,566 mutant mouse lines and identify 198 genes whose
disruptions yield NeuroAnatomical Phenotypes (NAPs), mostly affecting structures impli-
cated in brain connectivity. Groups of functionally similar NAP genes participate in pathways
involving the cytoskeleton, the cell cycle and the synapse, display distinct fetal and postnatal
brain expression dynamics and importantly, their disruption can yield convergent phenotypic
patterns. 17% of human unique orthologues of mouse NAP genes are known loci for cognitive
dysfunction. The remaining 83% constitute a vast pool of genes newly implicated in brain
architecture, providing the largest study of mouse NAP genes and pathways. This offers a
complementary resource to human genetic studies and predict that many more genes could
be involved in mammalian brain morphogenesis.
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Brain morphogenesis is a complex process requiring coor-dinated development of multi-scale structures and relies ona system of sophisticated cues, which together contribute to
the proper formation of neural circuits and higher-order cogni-
tive functions. Genetic inheritance has a signiﬁcant role in brain
morphogenesis as shown in twin studies1. How many genes
inﬂuence brain morphogenesis and what functional systems these
genes operate in are important unsolved problems in develop-
mental biology.
Several recent genome-wide association studies identiﬁed
common genetic variants at ﬁve loci that together explained
between 15% and 25% of the variance inﬂuencing intracranial
volume2,3. However, malformations of brain development,
affecting about 0.5% of children4, are due to rare mutations of
large effect size that are frequent causes of intellectual disability
(ID)5,6, autism spectrum disorders (ASDs)7,8, and schizophrenia9.
These disorders originate from defects in neurogenesis, cell sur-
vival, neuronal migration, axon guidance, and synaptogenesis,
and while our capacity to detect genetic variants has signiﬁcantly
improved10, distinguishing pathogenic mutations from normal
variation remains an issue11. Their disabling nature together with
the fact that as many as 60% of cases are of unknown genetic
etiology6 also calls for ways to improve clinical identiﬁcation and
functional stratiﬁcation, as both are key for better treatment.
Given that combined genetic and large-scale anatomical analysis
of the human brain is technically challenging at high resolution, we
turned to the mouse where both the environment and genetic
background are controlled and where cell-level resolution is
achievable using histology. Although the complex cortical folding
of the human brain is absent in the naturally lissencephalic rodent
brain, humans and rodents share neurodevelopmental principles.
This view is supported by the identiﬁcation of mutations in mice
even before their implication in human cerebral developmental
disorders, such as TUBA1A12 and EML113, demonstrating that
mutations in the mouse translate to the clinic14. Here we utilize a
reverse-genetic screen in mice and perform a systematic and
accurate assessment of neuroanatomical defects in 1566 genetic
mutant lines in order to identify key genes and functional path-
ways modulating brain morphogenesis. We then show how this
resource can help gain insights into the biological mechanisms
leading to neurodevelopmental and psychiatric disorders.
Results
Gene identiﬁcation for NeuroAnatomical Phenotypes (NAPs).
Through collaboration with the Sanger Institute Mouse Genetics
Project, a partner of the International Mouse Phenotyping Con-
sortium (IMPC), we obtained brain samples from 4796 adult
male mice for heterozygous and/or homozygous or hemizygous
mutations (Supplementary Notes), as well as 1418 matched wild
types (WTs). In all, 88% of mouse mutants were generated using
the Knockout-ﬁrst allele method15 (Supplementary Data 1; Sup-
plementary Notes). To maximize the number of alleles tested,
only males were analyzed in this study despite evidence of sexual
dimorphism in mammalian brain-related traits16.
This dataset represents 1566 alleles, each studied with three
biological replicates, from 1446 unique genes (Supplementary
Notes), of which 1394 are protein coding, 32 single or multiple
RNA genes, 10 CpG islands, 4 unclassiﬁed, 3 chromosomal
deletions, 2 pseudogenes, and 1 gene segment (Supplementary
Data 1). Multiple constructions were analyzed for 105 of these
genes including allelic variants at 43 loci, 29 studied both at
heterozygous and homozygous state, 19 at different age points
(mainly 6 and 16 weeks of age), and the remaining 29 were a
mixture of these or additional controls (Supplementary Data 2;
Supplementary Notes). Overall, 80% of alleles were maintained
on a pure inbred C57BL/6N background, 18% on mixed C57BL/6
backgrounds, and 2% with other genetic backgrounds (129, CBA
and C3Fe), the latter being always analyzed alongside matched
controls since the neuroanatomy of these strains of mice can
signiﬁcantly differ from one another (Supplementary Notes).
Neuroanatomical data were collected down to cell-level
resolution blind to the genotype using a histological pipeline
(Supplementary Fig. 1a; Supplementary Notes) on symmetrical
and stereotaxic planes of the adult mouse brain at Bregma
+0.98 mm, −1.34 mm, and −5.80 mm as well as at Lateral
0.60 mm (named critical sections)17. The sagittal plane offers
beneﬁts we discussed elsewhere18, while essentially covering and
enabling us to detect NAP variation in the same structures
present on coronal sections19. Eighty-ﬁve co-variates (Supple-
mentary Data 3) and 118 brain morphological parameters mainly
consisting of area (63%) and length (36%) measurements of
anatomical structures (Supplementary Fig. 2; Supplementary
Data 4) were quantiﬁed (Supplementary Data 5) and stored into a
relational database (Supplementary Fig. 3; Supplementary Notes).
These parameters encompass six main categories: brain size,
commissures (callosal, anterior, hippocampal, fornix, and stria
medullaris), ventricles (lateral, third, and fourth), cortex (motor,
somatosensory, cingulate, piriform, retrosplenial, and temporal),
subcortex (hippocampus, amygdala, tracts, caudate putamen,
internal capsule, habenula, ﬁmbria, thalamus, hypothalamus,
substantia nigra, subiculum, and colliculus), and cerebellum
(granule layer, cerebellar nuclei, number of folia, pons, nerves,
and pontine nuclei) (Fig. 1a; Supplementary Data 4). A two-
dimensional (2D) map of brain parameters from WT animals
plotted using a dimensionality reduction method (t-Distributed
Stochastic Neighbor Embedding (t-SNE)) revealed the expected
clusters of related anatomical features within and across critical
sections (Supplementary Fig. 4a) arguing that data structure
was preserved and sound. Brain structural correlation analysis is
also provided in Supplementary Fig. 4b–d on raw and normalized
data (to the total brain area) sets (see Supplementary Notes for
more details).
A standardized statistical pipeline for the detection of neuroa-
natomical phenotypes was developed in R using PhenStat, a
package providing a variety of statistical methods for the analysis of
large-scale phenotypic associations from the IMPC20 (Supplemen-
tary Fig. 5; Supplementary Notes). Using PhenStat’s linear mixed
model (LMM) framework (https://bioconductor.org/packages/
release/bioc/vignettes/PhenStat/inst/doc/PhenStatUsersGuide.pdf),
the necropsy date of the animal was computed as a random effect
variable in order to account for temporal variation that may have
occurred since the start of the study in 2009. This achieved the best
ﬁtting model (highest Maximum Likelihood Estimate score) against
other models taking into account co-variates such as body or brain
weights and total brain area (Supplementary Fig. 5; Supplementary
Notes). Alleles maintained on mixed inbred strain backgrounds (2%
of the data) were analyzed independently using Student’s t test
(Supplementary Data 6). The study’s statistics are detailed
in Supplementary Notes.
We identiﬁed 198 genes associated with neuroanatomical
defects (Fig. 1b; Supplementary Data 7) at the adjusted
Benjamini–Hochberg p value (BH-p) of <0.1, hereafter named
as NAP genes. Brain abnormalities were annotated using existing
or newly created Mammalian Phenotype Ontology (MPO) terms
(Supplementary Data 8). A heat map of all tested genes is
provided in Supplementary Data 9. Percentage change, z-score,
and unadjusted and adjusted p values are listed in Supplementary
Data 10. Commissures were most affected (32%), followed by
subcortical malformations (21%), ventricles (18%; frequently
enlarged), cortical anomalies (17%), brain size defects (10%), and
cerebellar/pons anomalies (2%) (Fig. 1b).
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The most severe cortical malformation detected is an occurrence
(Eml1−/−) of subcortical heterotopia with thinner homotopic
cortex and abnormal ﬁber tracts surrounding it (Fig. 2a)
reminiscent of a previous Eml1-spontaneous mouse mutant21,
but our screen identiﬁed additional defects: corpus callosum
dysgenesis, abnormal hippocampus, and enlarged ﬁmbria. Eml1 is
one of the 51% of NAP genes that impacted on two or more brain
categories. Examples of global impact on brain architecture include
Camsap3−/− and Pfn1+/− (Fig. 2b). Camsap3−/− is a representa-
tive example of microcephaly where the total brain area, the
cingulate cortex, the genu of the corpus callosum, the anterior
commissure, the soma of the corpus callosum, and the internal
capsule were all reduced in size, ranging from −12% to −71% (for
details, see Supplementary Data 10). Pfn1+/− is an illustrative
example of extreme but complex hydrocephaly where other
regions are making up for lost space: the total brain area, the
cingulate cortex, the genu of the corpus callosum, the caudate
putamen, the anterior commissure, the motor cortex, and the
retrosplenial cortex were all reduced in size, ranging from−16% to
−32% (BH-p < 0.1; LMM), while the ventricles and the height of
the corpus callosum were increased ranging from +28% to +633%
(BH-p < 0.02; LMM). Other examples of models with global
impacts include Akap9+/−, Cbx6−/−, Daam2−/−, Mysm1+/−,
Rnf10−/−, Ropn1l−/−, and Trappc10−/− (Supplementary Data 9).
On the other hand, Abcb6−/−, Slitrk4−/Y, and Sytl1−/− had an
impact on the size of two brain regions (see Fig. 2c for Slitrk4−/Y:
−15.2%, BH-p= 0.009 for the somatosensory cortex and −12.9%,
BH-p= 0.07 for the cerebellum; LMM). The remaining 49%
caused speciﬁc abnormalities pertaining to a single category, of
which 80% affected a single parameter. For example, Sik3−/−
altered the anterior commissure (−39.5%, BH-p= 1.98E-08;
LMM), Anks1b−/− the dorsal hippocampal commissure
(+91.4%, BH-p= 1.24E-06; LMM) (Fig. 2d), and Sgms1−/− the
size of the ventricles (−167%, BH-p= 0.01; LMM) (Fig. 2e). In
all, 46% of NAP genes decreased the size of the affected structures,
while 38% increased their sizes (mainly ventricles) and only
16% had bidirectional effects (Fig. 1b). We deﬁned four severity
groups based on the percentage change relative to WTs
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Fig. 1 Gene identiﬁcation for neuroanatomical phenotypes. a One hundred and eighteen brain parameters (Supplementary Data 4; Supplementary Fig. 2)
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(Supplementary Fig. 1b): mild (0–10%), moderate (10–20%),
severe (20–40%), and very severe (>40%), the latter two groups
being the most common with the maximum being 727% for the
ventricles in Cep41−/−.
The vast majority of NAP genes (94%) have never been
previously assessed and associated with brain anatomy in mice,
for example, loss of Smyd5, a lysine methyltransferase gene,
increases the retrosplenial granular cortex by 17.5% (BH-p=
0.01; LMM). The remaining reproduced previous mouse reports
(Supplementary Data 1), for example, inactivation of Dlg3, a
postsynaptic gene associating with GluN2 subunits of N-methyl-
D-aspartate (NMDA) receptors, yield a smaller cortex and white
matter structures as shown previously22 but also decreases
hippocampal size (−25.4%, BH-p= 0.08; LMM).
To assess experimental sensitivity, we compared the 1248 non-
NAP genes and their phenotypic associations against existing
MPO annotations from the Mouse Genome Informatics (MGI)
database23 and identiﬁed only one gene reported previously
(Trappc9) for which we did, however, detect a low-conﬁdence
neuroanatomical change. We demonstrated experimental repro-
ducibility using technical repeats of 120 mutant lines engineered
twice using various constructions, which showed consistent
results, with the exception of Fundc1 (Supplementary Data 2).
Relevance to human neurodevelopmental diseases. As the fol-
lowing analyses required full datasets, a Bayesian mixed model
approach24 was used to impute missing data (Supplementary
Data 11) in a subset comprising 1380 alleles representing samples
with C57BL/6 background at similar age (Supplementary
Data 12). The same statistical framework than for non-imputed
datasets was used (Supplementary Data 13) yielding a consistent
set of 196 NAP genes at the adjusted p value (BH-p) of <0.1
(Supplementary Data 14; Supplementary Fig. 6; Supplementary
Notes). Unique human (1:1) orthologs were identiﬁed for 173 of
these 196 mouse NAP genes.
To examine the relevance of genes associated with mouse
neuroanatomical phenotypes to humans, we ﬁrst compared the
features of human unique orthologs of genes whose disruption in
mouse models yielded the largest neuroanatomical variation (top
10%) to those study genes showing the least (bottom 10%) and
evaluated differences to randomly permutated gene sets (Supple-
mentary Notes). The human orthologs of top 10% genes (i)
undergo strong negative selection (dN/dS), (ii) have relatively
high selection coefﬁcients (shet), (iii) are more likely to be
haploinsufﬁcient (HIS), (iv) are depleted of genetic variation
(RVIS (Residual Variation Intolerance Score)), and (v) are
predicted to be intolerant to protein-truncating mutations (pLI
(probability of being Loss of function Intolerant)) (Fig. 3a–c).
More generally, we found a signiﬁcant correlation between three
of these measures and the strength of brain abnormalities
(deﬁned as the maximum absolute z-score deviation from WT
mice) induced by disruptions of the associated mouse orthologs
(p= 0.050, p= 0.038, and p= 7.7E10−5 for shet, RVIS, and pLI,
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Fig. 3 Predicted gene deleteriousness in humans. a Mouse lethal genes51
and the top 10% of mutants with the largest neuroanatomical abnormalities
are compared to the bottom 10% and to randomly permuted sets of these
genes. The dN/dS ratio examines selection pressures by comparing the rate
of synonymous and non-synonymous substitutions. b, c Comparison of the
gene properties of the human orthologs of lethal genes51 and of the top 10%
of mutants with the largest neuroanatomical abnormalities as compared to
genes in the bottom 10% and to randomly permuted sets of these genes. shet
(Selection coefﬁcient associated with the loss of heterozygosity), RVIS
(Residual Variation Intolerance Score), and pLI (probability of being Loss of
function Intolerant) are all indicators of purifying selection pressure, while
HIS are predicted HaploInsufﬁciency Scores (Supplementary Notes). d The
overlap between gene sets from A and B with MIM Morbid Map genes.
e Enrichments of intellectual disability-associated genes from three
independent publications and developmental disorder-associated genes
(Supplementary Notes) among human orthologs of NeuroAnatomical
Phenotype (NAP) genes compared to human orthologs of non-NAP. *0.05 <
p < 0.01; **0.01 < p < 0.001; ***p < 0.001 (right-tailed Mann–Whitney U test
for a–d and right-tailed Fisher’s test for e)
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respectively; linear regression). While not globally enriched in
known human disease genes (Fig. 3d), we found an excess of ID-
associated genes from three independently curated gene lists25–27
(p < 0.005 for all sets; right-tailed Fisher test) (Fig. 3e). Although
no excess of autism genes was found (Supplementary Fig. 6), we
observed an overrepresentation of a subset of ID-associated genes
comorbid with ASD (p= 0.0015 and odds ratio= 8.50; right-
tailed Fisher test)25.
Next, using the manually curated catalog of 1108 primary
human ID-associated genes (SysID database; https://sysid.cmbi.
umcn.nl/; June 2018 download), 56% (627) of which account for
ID without brain malformations and 43% (481) for ID co-
occurring with brain malformations26, we identiﬁed an overlap of
30 NAP genes (Supplementary Data 15) of human unique
orthologs of genes whose disruption in mouse models yielded
neuroanatomical phenotypes (BH-p < 0.1; LMM). Nineteen of the
30 genes (AP4E1, AP4M1, ASPM, AUTS2, CDK5RAP2, CENPJ,
CEP41, CTCF, DCX, DONSON, EHMT1, HERC1, KPTN, LAMC3,
MCPH1, ORC1, SLC16A2, TCF4, and TMEM165) are linked to
highly or fully penetrant brain structural abnormalities (mainly
microcephaly/macrocephaly) in many patients and for which 4
genes (ASPM, CENPJ, DCX, and LAMC3) had been previously
reported using mouse models, while the remaining 15 are new
in vivo mouse models exhibiting equivalent neuroanatomical
defects to humans (with the exception of DONSON). The
identiﬁcation of ﬁner-scale structural anomalies pertaining to
the commissures in these models further supports brain
connectivity perturbation as a common disease mechanism for
ID. Eleven of the 30 genes (ADAR, ANO10, C12orf4, CEP120,
DLG3, DLG4, GBA2, GTPBP3, PSPH, SLC5A7, and ZC3H14) are
primary ID genes annotated as not known to be associated with
structural brain malformations, although when we used a
different source (OMIM or Pubmed), low-penetrance structural
brain anomalies were, however, reported for some of these genes
(Supplementary Data 15).
Of the remaining 143 (83%) human unique orthologs of
mouse NAP genes that did not overlap with primary ID-
associated disease genes, our data may help in improving clinical
interpretation especially if the identiﬁcation of additional
cases proves difﬁcult or when the pathogenicity of variants is
uncertain. For example, a novo missense mutation in CAM-
SAP328, a gene involved in the regulation of microtubules
dynamics, segregates in one patient with a nervous system
phenotype in the Deciphering Developmental Disorders study29.
Camsap3 mutation in mice yielded major neuroanatomical
defects, including microcephaly and thin corpus callosum. Our
data can also help in dissecting copy number variation regions
associated with brain defects in neurodevelopmental cohorts
(Supplementary Data 16). For example, ARVCF, localized to the
22q11.21 region has been linked to schizophrenia30. Our study
associates disruption of Arvcf with abnormalities in the striatum
(smaller), while in the Simons Simplex Collection31 we identiﬁed
a de novo nonsense mutation affecting ARVCF in an ASD patient
presenting with microcephaly. These observations suggest that
the less-studied gene ARVCF may have a prominent etiological
role in the 22q11.21 neurodevelopmental disease-associated
phenotypes.
Functional characterization of NAP genes. Genomic data
sources including gene expression, protein–protein interactions
(PPIs) and functional mouse and human datasets were used to
identify functional convergence among mouse NAP genes derived
from our largest and most powerful dataset on coronal sections
(Supplementary Notes). Randomly permutated gene sets drawn
from the genomes were used as controls.
Our 158 mouse coronal NAP genes showed a strong
interconnectedness within a large-scale functional gene network
(Fig. 4a; MouseNet) supporting overall functional similarities and
participation in shared molecular pathways. Gene ontology (GO)
enrichment analysis revealed that mouse NAP genes are localized
to the cytoskeleton and microtubules (Supplementary Fig. 7). Roles
in synaptic transmission were supported by an excess of
postsynaptic density (PSD) and Fragile X Mental Retardation
Protein (FMRP) target genes (p= 0.017 and p= 0.0035, respec-
tively; Fig. 4b; right-tailed Fisher test). Mouse NAP genes are
strongly expressed in the developing central nervous system (CNS),
and in particular, upregulated during early/mid (E11.5–E14)
prenatal development (Fig. 4c). Within the co-expression network
(Supplementary Fig. 8), the genes associate with ﬁve separate
clusters (named mouse modules) with distinct fetal- and adult-
expressed brain temporal expression dynamics (Fig. 4d).
Unique human (1:1) orthologs were identiﬁed for 147 of the 158
mouse NAP genes (Supplementary Data 1; Supplementary Notes)
and displayed similar functional annotations to mouse genes
(Supplementary Fig. 7). They are expressed in the human brain
(Fig. 4b), and in particular, upregulated not only during early/mid
prenatal development (Fig. 4e), consistent with the mouse dataset,
but also throughout infancy and childhood (Fig. 4e) but do not
show region-speciﬁc expression (Fig. 4f). Human orthologs of
mouse NAP genes cluster strongly within a Phenotypic Linkage
Network (PLN; randomisations p < 0.001; Fig. 4a), an integrated
gene network constructed by combining several human genomic
data sources32. These results are replicated using a PPI network and
high-coverage unbiased body-wide and brain developmental gene
co-expression networks (Fig. 4a; Supplementary Data 17).
Sub-clustering of the 147 unique human orthologs within the
PLN network reveals nine functionally distinct gene modules
(Fig. 5a). Similar mouse modules were uncovered when grouping
NAP genes based on gene expression dynamics across the
developing mouse CNS (Supplementary Fig. 8), reinforcing the
relevance of translational studies between human and mouse. The
human module 2 was enriched for cell cycle-related GO
annotations speciﬁcally the G2/M checkpoint (Fig. 5a; Supple-
mentary Data 18), implicating these genes in early neurodevelop-
mental processes. By contrast, human modules 0 and 7 exhibit an
excess of brain-speciﬁc (p= 0.002 and p= 0.045, respectively;
right-tailed Fisher’s test) and human orthologs of FMRP target
genes (p= 7.81E−04 and p= 0.030, respectively; Fig. 5b; right-
tailed Fisher test). Moreover, module 0 is also enriched for human
orthologs of mouse PSD and synaptosome genes (p= 7.81E−04
and p= 0.019, respectively; Fig. 5b; right-tailed Fisher’s test) and
the associated genes are functionally annotated with the GO
terms PSD (BH-p= 0.0015; right-tailed hypergeometric test), cell
projection (BH-p= 0.040; right-tailed hypergeometric test), and
cytoskeleton (BH-p= 0.026; right-tailed hypergeometric test)
(Supplementary Data 18). While both modules possess neuronal
functions, genes from module 0 are upregulated postnatally, while
those in module 7 are upregulated in the fetal brain (Fig. 5c),
suggesting that each module contributes to distinct neurodeve-
lopmental and mature synaptic functions. Accordingly, modules
7 and 0 are enriched in different subsets of fetally and postnatally
expressed FMRP target genes (p= 0.0038 and p= 0.0055,
respectively; Fig. 5b; right-tailed Fisher test). In humans,
disruptions of genes within the same neurodevelopmental
pathway cause a similar pattern of pleiotropic phenotypes33.
Correspondingly, while no speciﬁc neuroanatomical abnormality
was overrepresented among mouse models of orthologs
belonging to the same human functional modules, an overall
phenotypic convergence was observed for modules 2, 7, and 8
(Fig. 5d; Supplementary Notes) revealing neurodevelopmental
pathway/phenotype relationships. Speciﬁcally, mouse orthologs of
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modules 2 and 7 yielded more similar brain abnormalities than
other NAP genes across Bregma +0.98mm but not Bregma
−1.34mm, while the opposite pattern was found for module
8 orthologs (Fig. 5d). Congruently, while genes from human
modules 2 and 7 are more strongly expressed across tissues
mapping to Bregma +0.98mm than Bregma −1.34mm,
those from module 8 are more highly expressed across Bregma
−1.34mm tissues (Fig. 5c).
FMRP-associated genes were found in excess in modules 0 and
7 (Fig. 5b). We hypothesized that inactivation of mouse Fmr1
gene itself would be associated with brain defects. Human
patients show a larger striatum and a tendency toward large head
size34. However, previous mouse MRI studies of Fmr1−/Y
revealed differences depending on the genetic background strain.
Fmr1−/Y C57BL/6J did not exhibit neuroanatomical defects35, yet
Fmr1−/Y FVB revealed a smaller striatum36. To overcome these
discrepancies, we studied an Fmr1−/Y model on a mixed C57BL/
6J/FVB background using techniques developed in this study
(Supplementary Notes). We detected a signiﬁcant enlargement of
the cingulate cortex (+18.8%, p= 7.6E-04; LMM) and the
hippocampus (+20%, p= 0.03; LMM) (Fig. 5e), while the total
brain area was marginally increased (+4.3%, p= 0.08; LMM). A
separate sagittal sectioning protocol that examined 22 additional
brain regions showed increased dentate gyrus and pyramidal area
of the hippocampus (+14.4%, p= 8.3E-04 and +24.2%, p= 1.7E-
03, respectively; LMM) (Supplementary Fig. 8).
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Finally, we assessed whether mouse NAP genes are associated
with whole-body traits. Among 26 categories of traits tested
(MGI), 3 showed excess in behavioral/neurological, growth, and
adipose traits (BH-p= 0.039, 0.0007 and 2.92E−05, respectively;
right-tailed Fisher test) (Supplementary Fig. 9). This was
conﬁrmed when removing known-ID genes; however, we were
unable to detect an association between local neuroanatomical
defects and speciﬁc behavioral measures. All together, these
mouse ﬁndings provide mechanistic insights into known disease-
causing genes and simultaneously provide in vivo models for
validation and interpretation of future cognitive disorders,
such as ID.
Discussion
Our study shows the importance of performing systematic neu-
roanatomical characterization in mutants as it offers the ﬁrst
anatomical genotype/phenotype map of the mouse brain with the
identiﬁcation of 198 NAP genes covering a variety of brain
malformations. The commissures are most affected and micro-
cephaly is more common than macrocephaly, in agreement with
human studies37.
Our ﬁndings are important in at least four respects. First, 94%
of NAP genes have never been previously associated with mouse
brain anatomy. Assessment of brain sections usually relies on
qualitative evaluation by the human eye, for example, corpus
callosum agenesis or hydrocephalus. Our quantitative and ultra-
standardized approach allows us to detect many more features
and more subtle phenotypes. For example, our analysis of the
mouse model of Fragile X is the ﬁrst to recapitulate the human
brain overgrowth defects38 with a larger hippocampal size of
about 20%. It is possible that our stringent criteria for evaluating
brain symmetry and positioning increased the sensitivity to detect
phenotypes where other neuroanatomical studies have not,
especially for the hippocampus whose size depends largely on
these two criteria.
Our study indicates that genetic mutations causing neuroana-
tomical defects impact the overall equilibrium of the brain
architecture. This is consistent with the fact that about half of
NAP genes had a global impact on brain morphology. For
example, ablation of Rnf10, which was recently linked to neuronal
synaptic activity via its interaction with GluN2A subunit of
NMDA receptors39, perturbs the whole brain. Physical pressures
also exist in the brain and the most obvious example is hydro-
cephalus. When hydrocephalus develops, as the ventricles expand
the distance between them decreases, impacting on the width of
the corpus callosum.
A neuroanatomical baseline reference is provided for 991
genetically identical WTs on the C57BL/6N background, showing
little inter-individual variation in most brain regions. However,
the size of the amygdala, whose heritability was the lowest in a
human study using twins40, displayed correspondingly higher
variation in our WTs. This might explain our inability to detect
genes associated with this structure. As a result, t-SNE 2D map
grouped the amygdala with other undeﬁned regions, but the vast
majority of measures did cluster in coherent brain structures.
Second, our NAP genes converge onto a small number of
groups (modules) of functionally similar genes participating in
shared cellular pathways involving the actin and microtubule
cytoskeleton, and the synapse, and the disruption of genes within
the same module can yield a similar pattern of neuroanatomical
abnormalities. While synapse biology is implicated in ASD8 and
schizophrenia9, it is only emerging in ID41. Our study indicates
that mechanisms conﬁned to subcellular compartments as subtle
as dendritic spines can translate into major neuroanatomical
features. For example, MAPK10, a candidate gene for ID26, which
yields a thick piriform cortex, has been shown to bind to a set of
postsynaptic proteins42. Anks1b−/− associated with a thickening
of the dorsal hippocampal commissure has been implicated in the
regulation of hippocampal synaptic transmission by controlling
GluN2B subunit localization43 and reported as the most
upregulated protein in synaptic fractions from Fmr1−/Y mice44.
These examples highlight that our measurements expose defects
in neuronal circuitry and synaptic plasticity. Our study
reveals an enrichment of NAP genes toward FMRP targets and
describes distinct spatiotemporal expression signatures that fol-
low a caudal to rostral direction. This suggests that the sub-
compartmentalization of brain structures45 is under strong
genetic control.
Third, our in vivo mouse models show a great capacity for
novel disease gene validation with 83% of NAP genes not yet
linked to any cognitive disorders, constituting a new pool of
candidate genes testable against human diseases. During the
course of our study, several of our mouse models for previously
unknown NAP genes (for example, Kptn, Donson, or Aff3) were
subsequently associated with causative mutations in recent
human studies46–48, suggesting that other genes identiﬁed in this
study may be validated in future studies. Also, it is noteworthy
that the rate at which new cases are diagnosed remains low
despite most cases being genetic in nature29. Ultimately, our
models offer a tangible chance of improving this discovery rate,
addressing the problem of missing pathogenicity that most large-
scale sequencing studies encounter and helping with disease
stratiﬁcation.
Importantly, our study justiﬁes the use of brain anatomy as a
common denominator of cognition, offering endophenotypes for
neurological or psychiatric disorders. For example, mutations of
SLITRK4 have been recently linked to schizophrenia through a
synaptic dysfunction mechanism49. In our study, Slitrk4−/Y dis-
played a smaller somatosensory cortex, in line with the under-
pinnings of sensory processing deﬁcits in patients with
schizophrenia. Our resource can also help decipher the etiology of
several important human birth defects causing perinatal or in
utero death and for which knowledge is lagging behind because of
ethical considerations and/or lack of biological material. Only
four genes (AP1S2, CCDC88C, L1CAM, and MPDZ) have been
associated so far with congenital hydrocephalus, a pathology
affecting 1:1000 live births50. Our top candidate gene for con-
genital hydrocephalus is Atad3a, associated with severe enlarge-
ment of the ventricles in the heterozygous state and previously
reported to be lethal when homozygously deleted51. Interestingly,
Harel and colleagues have recently reported a biallelic deletion of
ATAD3A associated with infantile lethality52.
In conclusion, our study represents the largest atlas of the
causal link between gene mutation and its associated neuroana-
tomical features to date. It contributes a breadth of new knowl-
edge on the genetics of brain morphogenesis and their underlying
networks, providing evidence as to the importance of the cytos-
keleton and the synapse in how the brain forms its structures in a
highly speciﬁc spatiotemporal manner, and adequately comple-
ments human genetic studies of neurodevelopmental and neu-
ropsychiatric disorders.
Methods
We provide a summary of our main methods below. A detailed description and any
associated references are available in Supplementary Notes.
Study samples and gene selection. A total of 6214 mice were analyzed corre-
sponding to 1566 allelic constructions for 1446 unique genes. Information related
to the construction of the mutant line such as allele, genotype, promoter, cassette,
diet, and background strain is provided in Supplementary Data 5. Most mouse
mutants were generated using the Knockout-ﬁrst allele method15. The strategy
relies on the identiﬁcation of an exon common to all transcript variants, upstream
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of which a LacZ cassette was inserted to make a constitutive knockout. A subset of
mutants were generated using CRISPR/Cas9 methodology, similar to previously
reported method53. Genes were selected for entry into the pipeline from requests by
WTSI faculty and collaborators working on a wide variety of ﬁelds, including
cancer, metabolism, infection, immunology, behavior, and human evolution, but
without a priori interest in the data generated from the brain histopathology
screen. In addition, genes without prior characterization were assigned by the
IMPC to WTSI for phenotyping. Assessed genes were distributed on all chromo-
somes except Y with no bias on their genomic distribution. One hundred and ﬁve
genes were studied multiple times for validation purposes (see Supplementary
Data 2 for details).
Data collection. Supplementary Fig. 1 shows the overall experimental workﬂow.
All standard operating procedures are described in more detail elsewhere17,18. In
general, brain samples were immersion-ﬁxed in 10% formalin for at least 48 h,
before parafﬁn embedding and sectioning at 5-μm thickness. Three coronal and
one sagittal sections were stereotatically deﬁned and named as critical sections.
These critical sections (Bregma +0.98 mm, Bregma −1.34 mm, Bregma −5.80 mm,
and Lateral 0.60 mm) were double-stained (Luxol Fast Blue for myelin and Cresyl
violet for neurons) and scanned at cell-level resolution using the Nanozoomer
whole-slide scanner 2.0HT C9600 series (Hamamatsu Photonics, Shizuoka, Japan).
A total of 85 co-variates, for example, sample processing dates and usernames,
were collected at every step of the procedure (Supplementary Data 3), as well as
118 brain morphological parameters of 77 area and 39 length measurements and
the number of cerebellar folia (Supplementary Data 4 and Supplementary Fig. 2).
All samples were also systematically assessed for cellular ectopia (misplaced
neurons).
Quality control. Brain images were systematically assessed to keep track of
potential drifts and ensure high quality. Each image was scored based on four
criteria: (1) suitability for analysis, (2) adequacy of the intensity and contrast of the
staining to properly delineate brain structures, (3) symmetry, and (4) sectioning
precision. By contrast to more conventional histopathological screens that often
rely on qualitative assessment, we used a quantitative approach where each section
had to pass well-deﬁned stereotaxic coordinates deﬁned according to the Mouse
Brain Atlas54 before image analysis. To do this, we recorded how close the image to
be analyzed was to the critical section (that is, at the precise stereotaxic position)
(Supplementary Fig. 5). Data quality being crucial for the interpretation of large-
scale projects, a thorough quality-control process was designed and implemented at
multiple steps of the experimental procedure. A lot of care was given to control
human errors and false-positive ﬁndings using an in-house quality-control
pipeline within a FileMaker Pro framework (Supplementary Fig. 5). A semi-manual
stepwise approach was implemented to standardize and facilitate data cleaning
process.
Statistical framework for gene identiﬁcation. To account for temporal variation
that may have occurred since the start of the study in 2009, we used a LMM
framework computing the necropsy date of the animal as a random variable. The
model was ﬁtted in R using a parallelized version of PhenStat (version 2.2.4), a
package developed for statistical analysis of large-scale phenotypic data from the
IMPC20. Supplementary Data 10 provides association and percentage change data
for 1566 assessed alleles across 48 left and right combined for coronal and 40 for
sagittal parameters. Relevant Mammalian Phenotype (MP) terms were used to
describe neuroanatomical defects, and when needed, new MP terms were created
speciﬁcally for this project through collaboration with the Jackson Laboratory
(http://www.informatics.jax.org/) (Supplementary Data 8). Multiple testing cor-
rections were performed using the Benjamini–Hochberg (BH) method. From this,
ﬁve gene lists were generated based on 1, 5, 10, 15, and 20% false discovery rate
(FDR) (see column C in Supplementary Data 10). To control for FDR, a set of 100
permutations was run within each subproject. The average number of signiﬁcant
genes in a set of 100 permutations was compared to the results of the true data.
Gene association was considered as signiﬁcant when the adjusted p value was <0.1.
Data imputation and imputed datasets. A newly developed imputation tool
(PHENIX version 1.024), based on a Bayesian multiple-phenotype mixed model
method, was used to overcome the problem of missing data in downstream ana-
lyses that relied on full datasets. This resulted in a new imputed dataset made of
1380 alleles from 1306 unique genes, totaling 5281 mouse samples (Supplementary
Data 12). The same statistical pipeline as the one applied to non-imputed data was
used (Supplementary Data 13), producing a new gene-association list (Supple-
mentary Data 14).
Genes causing strongest and weakest NAP. Z-score deviations of mutant gene
replicates from the average of matched controls were estimated for each brain
parameter list (Supplementary Data 14). Considering only the 960 mutant genes
with 1:1 human orthologs, we selected the 10% of genes associated with the highest
(top) and lowest (bottom) absolute z-score values across features (n= 96). We
formed 1000 permuted sets of top 10% genes by randomly drawing the same
number of genes from human mutant orthologs (n= 96). Consistent results were
found using 1%, 5 and 15% top and bottom, and when deﬁning them using
cumulative absolute z-scores across brain parameters, although the signals were
weaker.
Phenotypic similarity. Considering 1:1 human orthologs of NAP genes, we re-
scored signiﬁcant abnormalities (BH-p ≤ 0.05) as 1 (presence) or otherwise 0 (BH-
p > 0.05; absence) for each gene and brain parameter. The similarity of defects
caused by the disruption of pairwise gene combinations was calculated using a
simpliﬁed version of the Goodall3 index55. Given the low incidence of signiﬁcant
abnormalities post BH correction (i.e., mean of 0.23 ± 0.92 defects per gene), we
examined the shared presence of abnormalities between gene pairs, weighted by
their overall frequency. This simpliﬁcation generated a more conservative index,
whereby strong similarity was not driven by genes lacking neuroanatomical defects.
The new similarity index was given by:
Sði; jÞk ¼
1 f 2k ;if k is present in both genes
0;if k is absent in both or present in one

where S(i,j)k is the Goodall3 measure between genes i and j for brain feature k and
fk is the proportion of NAP orthologs associated with abnormalities in k. The
overall phenotypic similarity of two human NAP orthologs was estimated as the
average similarity across Bregma +0.98 mm and −1.34 mm.
Gene networks. The mouse and human gene networks downloaded or constructed
(and associated references) are summarized in Supplementary Data 21. We
downloaded MouseNet v2, a functional mouse gene network incorporating various
mouse -omics resources (i.e., PPI, gene expression data, functional annotations,
and homology data)56. We constructed human body-wide and brain spatio-
temporal gene co-expression networks, using GTEx57 and BrainSpan58 RNA
sequencing data across 51 bodily tissues and across 27 brain tissues spanning 12
developmental stages, respectively. Genes with FPKM (Fragments Per Kilobase of
transcript per Million mapped reads) or RPKM (Reads Per Kilobase of transcript
per Million mapped reads) values <1 in >95% of samples were excluded and gene
co-expression networks were derived by estimating the correlation of expression
patterns of pairs of protein-coding gene across all associated samples, using
Pearson’s coefﬁcients59. Human PPI networks were downloaded from String60.
Lastly, by combining various human genomic datasets (i.e., PPIs, GO, MGI, KEGG,
Reactome, and gene expression data), we constructed an integrated gene network,
termed PLN, wherein pairs of gene are assigned scores, reﬂecting their likelihood of
functional interaction, based on multiple lines of evidence32.
Clustering and module identiﬁcation. To examine the network interconnected-
ness of a set of genes, we compared the sum of their network links to that of
permuted gene sets, constructed by randomly sampling the same number of
human genes, matched for CDS and network connectivity32. By running 1000
permutations, we derived an empirical p value, reﬂecting the fraction of rando-
mized gene sets, which are more interconnected in the evaluated network, than the
set of interest. We identiﬁed modules of strongly interconnected genes by parti-
tioning gene networks using the Louvain algorithm61. This greedy optimization
method attempts to maximize the modularity of a network division (strength of
connections inside modules as compared to between modules). The algorithm was
implemented in Gephi using a resolution parameter of 1.
Ethical considerations in animal use. The care and use of mice in the Wellcome
Sanger Institute study was carried out in accordance with UK Home Ofﬁce reg-
ulations, UK Animals (Scientiﬁc Procedures) Act of 1986 under two UK Home
Ofﬁce licenses (80/2485 and P77453634) that approved this work, which were
reviewed regularly by the Wellcome Sanger Institute Animal Welfare and Ethical
Review Body.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
We have provided all the data produced in this study within the article and its
associated supplementary information and data ﬁles.
Code availability
All bioinformatics analyses for this study were performed using R. PhenStat and
PHENIX packages are available for free download from https://www.bioconductor.org/
packages/devel/bioc/html/PhenStat.html and https://mathgen.stats.ox.ac.uk/
genetics_software/phenix/phenix.html. In-house R scripts used for the identiﬁcation of
genes are available upon request.
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